Related Experiment Video
Updated: Aug 12, 2026

Induction of Murine Intestinal Inflammation by Adoptive Transfer of Effector CD4+CD45RBhigh T Cells into Immunodeficient Mice
Published on: April 21, 2015
CCL25/CCR9 promotes the induction and function of CD103 on intestinal intraepithelial lymphocytes
Anna Ericsson1, Marcus Svensson, Anu Arya
1Immunology Section, Department of Cell and Molecular Biology, Lund University, Lund, Sweden.
Insights
The chemokine receptor CCR9 (C-C chemokine receptor type 9) and its ligand CCL25 promote CD103 (integrin alphaE) induction and function on CD8(+) T cells in the small intestine. This regulates lymphocyte-epithelial interactions.
Area of Science:
- Immunology
- Cell Biology
- Gastroenterology
Background:
- CD103 and CCR9 are co-expressed on small intestinal CD8(+) intraepithelial lymphocytes (IEL).
- CCR9's role in regulating CD103 expression and function on CD8(+) T cells is suggested but not fully understood.
- CD103 expression is altered upon T cell activation and migration to the small intestine.
Purpose of the Study:
- To investigate the role of CCR9 in the regulation of CD103 expression and function on CD8(+) T cells in the small intestine.
- To elucidate the mechanisms by which CCR9/CCL25 signaling influences CD103-mediated lymphocyte-epithelial interactions.
Main Methods:
- Flow cytometry analysis of CD8(+) T cells in mesenteric lymph nodes and small intestinal epithelium.
- Analysis of CD103 induction kinetics in wild-type and CCR9(-/-) CD8(+) T cells.
- In vitro adhesion assays using mEFc fusion protein and CD8(+) IEL stimulated with CCL25.
Main Results:
- CD103 is down-regulated on activated CD8(+) T cells in mesenteric lymph nodes, while effector cells entering the small intestine are initially CCR9(+)CD103(-).
- CCR9(-/-) CD8(+) T cells show delayed CD103 induction in the small intestinal epithelium.
- CCL25 induces CD103-mediated adhesion of CD8(+) IEL to mEFc in a dose-dependent and pertussis toxin-sensitive manner.
Conclusions:
- CCR9 signaling is crucial for the induction and function of CD103 on CD8(+) IEL in the small intestine.
- The CCR9/CCL25 axis plays a significant role in regulating CD8(+) T cell interactions with the small intestinal epithelium.
- These findings highlight a novel mechanism for controlling immune cell trafficking and function in the gut mucosa.
Abstract:
The integrin CD103 and the chemokine receptor CCR9 are co-expressed on small intestinal CD8(+) intraepithelial lymphocytes (IEL), naïve murine CD8(+) T cells and by a small population of effector/memory CD8(+) T cells, indicating a potential role for CCR9 in regulating CD103 expression and function. Here, we demonstrate that CD103, in contrast to CCR9, is down-regulated on CD8(+) T cells following their activation in mesenteric lymph nodes and that effector CD8(+) T cells upon initial entry into the small intestinal epithelium are CCR9(+)CD103(-). CD103 was rapidly induced on wild-type CD8(+) T cells subsequent to their entry into the small intestinal epithelium, however, CCR9(-/-) CD8(+) T cells exhibited a significant delay in CD103 induction at this site. In addition, the CCR9 ligand, CCL25, that is constitutively expressed in the small intestinal epithelium, induced transient, dose-dependent and pertussis toxin-sensitive CD103-mediated adhesion of CD8(+) small intestinal IEL to a murine E-cadherin human Fc (mEFc) fusion protein. Together, these results demonstrate a role for CCR9/CCL25 in promoting the induction and function of CD103 on CD8(+) IEL and suggest that this chemokine receptor/chemokine pair may function to regulate lymphocyte-epithelial interactions in the small intestinal mucosa.
Related Concept Videos
Renewal of Intestinal Stem Cells
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease III: Crohn's Disease

